Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP363087.RA0E_fYUwWSSCGS83MFEJ3DfKXNQg0eIrcdxy-a2A89wQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP363087.RA0E_fYUwWSSCGS83MFEJ3DfKXNQg0eIrcdxy-a2A89wQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP363087.RA0E_fYUwWSSCGS83MFEJ3DfKXNQg0eIrcdxy-a2A89wQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP363087.RA0E_fYUwWSSCGS83MFEJ3DfKXNQg0eIrcdxy-a2A89wQ130_provenance.
- NP363087.RA0E_fYUwWSSCGS83MFEJ3DfKXNQg0eIrcdxy-a2A89wQ130_assertion description "[Treatment of melanoma-patient-derived TAFs with IL-1?/? significantly enhanced their ability to suppress the proliferation and function of melanoma-specific cytotoxic T cells, and this inhibition was partially attributable to upregulation by IL-1 of COX-2 and the PD-1 ligands PD-L1 and PD-L2 in TAFs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP363087.RA0E_fYUwWSSCGS83MFEJ3DfKXNQg0eIrcdxy-a2A89wQ130_provenance.
- NP363087.RA0E_fYUwWSSCGS83MFEJ3DfKXNQg0eIrcdxy-a2A89wQ130_assertion evidence source_evidence_literature NP363087.RA0E_fYUwWSSCGS83MFEJ3DfKXNQg0eIrcdxy-a2A89wQ130_provenance.
- NP363087.RA0E_fYUwWSSCGS83MFEJ3DfKXNQg0eIrcdxy-a2A89wQ130_assertion SIO_000772 22850568 NP363087.RA0E_fYUwWSSCGS83MFEJ3DfKXNQg0eIrcdxy-a2A89wQ130_provenance.
- NP363087.RA0E_fYUwWSSCGS83MFEJ3DfKXNQg0eIrcdxy-a2A89wQ130_assertion wasDerivedFrom befree-20140225 NP363087.RA0E_fYUwWSSCGS83MFEJ3DfKXNQg0eIrcdxy-a2A89wQ130_provenance.
- NP363087.RA0E_fYUwWSSCGS83MFEJ3DfKXNQg0eIrcdxy-a2A89wQ130_assertion wasGeneratedBy ECO_0000203 NP363087.RA0E_fYUwWSSCGS83MFEJ3DfKXNQg0eIrcdxy-a2A89wQ130_provenance.
- befree-20140225 importedOn "2014-02-25" NP363087.RA0E_fYUwWSSCGS83MFEJ3DfKXNQg0eIrcdxy-a2A89wQ130_provenance.